New epidemiologic perspectives concerning mild-to-moderate heart failure

The American Journal of Medicine
K F Adams

Abstract

Heart failure is emerging as a major component of the public health problem of cardiovascular disease as we move into the twenty-first century. Current statistics indicate 4.9 million US citizens are afflicted with direct treatment costs estimated to be $18.8 billion per year. These figures are expected to worsen substantially as the prevalence of heart failure continues to increase. Epidemiologic studies also point to important increases in morbidity and have identified risk factors that aid in prognosis and that may contribute to our mechanistic understanding of heart failure pathophysiology. In addition, epidemiologic results indicate that many patients with mild-to-moderate clinical heart failure are still at substantial risk for morbidity and mortality during follow-up periods of only a few years. These data highlight the importance of enhancing physician and public awareness of heart failure. New methods of molecular epidemiology will point toward better and earlier detection of this common and frequently fatal condition.

References

Aug 1, 1992·Journal of the American College of Cardiology·D D SchockenE A Ross
Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Jan 1, 1985·Social Science & Medicine·B Abel-Smith
Dec 23, 1971·The New England Journal of Medicine·D Littmann
Dec 23, 1971·The New England Journal of Medicine·P A McKeeW B Kannel
Oct 1, 1984·The American Journal of Cardiology·A H DoughertyR A Goldstein
Jul 1, 1995·American Heart Journal·D J LenihanR A Walsh
Feb 1, 1995·Journal of Internal Medicine·H Eriksson
Aug 1, 1994·British Heart Journal·W B KannelT Thom
Oct 1, 1993·American Heart Journal·R F Gillum
Oct 1, 1993·Journal of the American College of Cardiology·K K HoD Levy
Apr 1, 1996·Journal of Internal Medicine·H J DargieT A McDonagh
Mar 1, 1996·Journal of Cardiac Failure·T Messner, B Petersson
Dec 1, 1996·Journal of the American College of Cardiology·K F AdamsG Koch
Feb 1, 1997·European Heart Journal·M R CowieD E Grobbee
Feb 1, 1997·European Heart Journal·F PoussetM Komajda
May 3, 1997·Lancet·M R WilkinsL A Brown
Dec 24, 1997·European Heart Journal·F Rodríguez-ArtalejoJ del Rey Calero
Mar 1, 1995·Journal of Cardiac Failure·M A KonstamJ C Johnson
Jan 20, 1998·Lancet·T A McDonaghH J Dargie

❮ Previous
Next ❯

Citations

Jun 29, 2004·Proceedings of the National Academy of Sciences of the United States of America·Atsushi SanbeJeffrey Robbins
Aug 19, 2007·The Journal of Clinical Investigation·Hiroyuki NakayamaJeffery D Molkentin
Nov 3, 2007·The Journal of Clinical Investigation·Joerg HeinekeJeffery D Molkentin
Jan 5, 2008·Journal of Applied Physiology·John P Konhilas
Jan 8, 2008·Health Care for Women International·Sandra K Plach
Feb 5, 2004·American Heart Journal·Teresita Corvera-TindelKathleen Dracup
May 29, 2007·Current Problems in Cardiology·G William Dec
Oct 18, 2011·Nursing in Critical Care·Renata Pereira de MeloSue Moorhead
May 26, 2004·Clinics in Laboratory Medicine·William E Winter, Ronald J Elin
Nov 3, 2004·The American Journal of Cardiology·Wendy Y LeeUNKNOWN Epidemiology, Practice, Outcomes, and Cost of Heart Failure (EPOCH) Study
Jan 2, 2007·Autonomic Neuroscience : Basic & Clinical·Miguel Debono, Elaine Cachia
Aug 17, 2004·Journal of Cardiovascular Pharmacology and Therapeutics·Jerry L Bauman, Robert L Talbert
Nov 3, 2004·Nature Reviews. Genetics·Choong-Chin Liew, Victor J Dzau
Feb 6, 2002·The Journal of Clinical Investigation·Cornel BadorffStefanie Dimmeler
Jun 29, 2006·Annals of the New York Academy of Sciences·Steven Horrobin
May 18, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Daniel Burkhoff, Shlomo A Ben-Haim
Mar 28, 2008·American Journal of Physiology. Cell Physiology·Zachary R HealyKonstantinos Konstantopoulos
Sep 25, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Lori J SokollChristiana Zingler
Mar 13, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Monica Forero McGrathAdolfo J de Bold
Oct 19, 2006·The Journal of Emergency Medicine·Douglas D MayoDick C Kuo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.